Trial Condition(s):

Contraception

Data on Oral Contraceptives Compliance in Non Stop Regimen (DOC Non Stop)

Bayer Identifier:

15253

ClinicalTrials.gov Identifier:

NCT01185678

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Adherence to the dosing scheme is the principal element of COC efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.

Inclusion Criteria
- Patients at the age of 18-50 requiring contraception, treated with oral contraceptives designed for the scheme 28 pills for 28 days. The decisions would be made at the discretion of the attending physician.
Exclusion Criteria
- Patients were not valid for analysis if the initial visit was before start of study in the country (retrospective documentation), or if they did not take oral contraceptives designed for the scheme 28 pills for 28 days.

Trial Summary

Enrollment Goal
8416
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Drospirenone (DRSP, BAY86-5131)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Poland

Status
Completed
 

Trial Design